India to Australia: Paracetamol Export Trade Route
India has recorded 2,171 verified shipments of Paracetamol exported to Australia, representing a combined trade value of $119.6M USD. This corridor is served by 49 active Indian exporters, with an average shipment value of $55.1K USD. The leading Indian exporter is IPCA LABORATORIES LIMITED, which accounts for 46% of total export value with 91 shipments worth $55.5M USD. On the buying side, NA is the largest importer in Australia with $54.4M USD in purchases. The top 3 suppliers — IPCA LABORATORIES LIMITED, SANOFI INDIA LIMITED, GRACURE PHARMACEUTICALS LIMITED — together control 58% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Australia Paracetamol corridor is one of India's established pharmaceutical export routes, with 2,171 shipments documented worth a combined $119.6M USD. The route is dominated by IPCA LABORATORIES LIMITED, which alone accounts for roughly 46% of all export value, reflecting the consolidated nature of India's paracetamol manufacturing sector.
Across 49 active suppliers, the average shipment value stands at $55.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with paracetamol's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 10.2%, placing it at rank #3 among India's top paracetamol export destinations globally.
On the import side, key buyers of Indian paracetamol in Australia include NA, SANOFI-AVENTIS AUSTRALIA PTY LTD, GLAXOSMITHKLINE CONSUMER HEALTHCARE and 137 others. NA is the single largest importer with 63 shipments valued at $54.4M USD.
Route Characteristics
- Average transit33 days
- Peak seasonQ1
- Primary modeSea freight
- Top portNHAVA SHEVA SEA (INNSA1)
Market Position
- Global rank#3
- Annual growth+10.2%
- Demand growth+11.1%
- Regulatory ease81/100
Top 10 Indian Paracetamol Exporters to Australia
Showing top 10 of 49 Indian suppliers exporting Paracetamol to Australia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | IPCA LABORATORIES LIMITED Avg $610.3K per shipment | 91 | $55.5M | 46.4% |
| 2 | SANOFI INDIA LIMITED Avg $56.8K per shipment | 129 | $7.3M | 6.1% |
| 3 | GRACURE PHARMACEUTICALS LIMITED Avg $35.0K per shipment | 176 | $6.2M | 5.2% |
| 4 | GRANULES INDIA LIMITED Avg $94.1K per shipment | 57 | $5.4M | 4.5% |
| 5 | OLIVE HEALTH CARE Avg $66.5K per shipment | 77 | $5.1M | 4.3% |
| 6 | SRI KRISHNA PHARMACEUTICALS LIMITED Avg $36.7K per shipment | 121 | $4.4M | 3.7% |
| 7 | OLIVE HEALTH CARE Avg $49.4K per shipment | 70 | $3.5M | 2.9% |
| 8 | CIPLA LIMITED Avg $10.9K per shipment | 287 | $3.1M | 2.6% |
| 9 | SRI KRISHNA PHARMACEUTICALS LIMITED Avg $49.5K per shipment | 62 | $3.1M | 2.6% |
| 10 | SANOFI INDIA LIMITED Avg $71.1K per shipment | 37 | $2.6M | 2.2% |
This table shows the top 10 of 49 Indian companies exporting paracetamol to Australia, ranked by total trade value. The listed exporters are: IPCA LABORATORIES LIMITED, SANOFI INDIA LIMITED, GRACURE PHARMACEUTICALS LIMITED, GRANULES INDIA LIMITED, OLIVE HEALTH CARE , SRI KRISHNA PHARMACEUTICALS LIMITED, OLIVE HEALTH CARE, CIPLA LIMITED, SRI KRISHNA PHARMACEUTICALS LIMITED , SANOFI INDIA LIMITED . IPCA LABORATORIES LIMITED is the dominant supplier with 91 shipments worth $55.5M USD, giving it a 46% market share. The top 3 suppliers together account for 58% of the total trade value on this route.
Showing top 10 of 49 total Indian exporters on the India to Australia Paracetamol export route.
Top 10 Paracetamol Importers in Australia
Showing top 10 of 140 known buyers in Australia receiving Paracetamol shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian paracetamol in Australia include NA, SANOFI-AVENTIS AUSTRALIA PTY LTD, GLAXOSMITHKLINE CONSUMER HEALTHCARE , HALEON AUSTRALIA PTY LTD, GLAXOSMITHKLINE CONSUMER HEALTHCARE, among 140 total buyers. The largest importer is NA, accounting for $54.4M USD across 63 shipments — representing 46% of all paracetamol imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NA | 63 | $54.4M | 45.5% |
| 2 | SANOFI-AVENTIS AUSTRALIA PTY LTD | 93 | $5.2M | 4.3% |
| 3 | GLAXOSMITHKLINE CONSUMER HEALTHCARE | 42 | $3.6M | 3.0% |
| 4 | HALEON AUSTRALIA PTY LTD | 40 | $3.3M | 2.7% |
| 5 | GLAXOSMITHKLINE CONSUMER HEALTHCARE | 37 | $2.8M | 2.3% |
| 6 | SANOFI-AVENTIS AUSTRALIA PTY LTD | 37 | $2.6M | 2.2% |
| 7 | TO, | 51 | $2.5M | 2.1% |
| 8 | GENERIC PARTNERS PTY LTD | 45 | $2.0M | 1.7% |
| 9 | APOTEX PTY LTD | 45 | $2.0M | 1.6% |
| 10 | HALEON AUSTRALIA PTY LTD. | 32 | $1.9M | 1.6% |
Showing top 10 of 140 Paracetamol importers in Australia on this route.
Top 10 Paracetamol Formulations Imported by Australia
Showing top 10 of 1,142 product formulations shipped on the India to Australia Paracetamol route, ranked by trade value
Australia imports a wide range of paracetamol formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — HARMLESS MEDICINES:APOHEALTH PARACETAMOLPAIN RELIEF 500MG TABLETS(PARACETAMOL FILM COATED TABLETS 500MG)(139840X10X10'S — accounts for $13.9M USD across 1 shipments. There are 1,142 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | HARMLESS MEDICINES:APOHEALTH PARACETAMOLPAIN RELIEF 500MG TABLETS(PARACETAMOL FILM COATED TABLETS 500MG)(139840X10X10'S | 1 | $13.9M | 11.6% |
| 2 | APOHEALTH PARACETAMOL PAIN RELIEF 500MGTABLETS (PARACETAMOL FILM COATED TABLETS500MG)(93580X1X100'S PACK=9358000 TABLE | 1 | $11.0M | 9.2% |
| 3 | APOHEALTH PARACETAMOL PAIN RELIEF 500MGTABLETS (PARACETAMOL FILM COATED TABLETS500MG)(84030X10X10'S PACK=8403000 TABLE | 1 | $8.4M | 7.0% |
| 4 | APOHEALTH Paracetamol Pain Relief 500mgTablets(Paracetamol Film Coated Tablets500mg)(47040x1x100's Pack=4704000 Tablet | 1 | $5.5M | 4.6% |
| 5 | HARMLESS MEDICINES:APOHEALTH ParacetamolPain Relief 500mg Tablets(Paracetamol Film Coated Tablets 500mg)(55510x10x10's | 1 | $5.5M | 4.6% |
| 6 | APOHEALTH PARACETAMOL PAIN RELIEF 500MGTABLETS(PARACETAMOL FILM COATED TABLETS500MG)(46430X1X100'S PACK=4643000 TABLET | 1 | $5.4M | 4.6% |
| 7 | PANADOL LIQUID CAPS (PARACETAMOL 500MG. | 49 | $4.1M | 3.4% |
| 8 | HARMLESS MEDICINES APOHEALTH PARACETAMOL PAIN RELIEF 500MG TABLETS (PARACETAMOL FILM COATED TABLETS 500MG) (10X10S) (2 | 1 | $2.5M | 2.1% |
| 9 | FINISHED DOSAGE FORM-PARACETAMOL MODIFIE | 39 | $2.1M | 1.8% |
| 10 | PHARMACEUTICAL PRODUCTS- APX-PARACETAMOL | 18 | $1.3M | 1.1% |
Showing top 10 of 1,142 Paracetamol formulations imported by Australia on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 78%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
NHAVA SHEVA SEA (INNSA1) handles the highest volume with 647 shipments. Transit time averages 33 days by sea.
Market Dynamics
India's paracetamol exports to Australia are driven primarily by a handful of large-scale manufacturers. IPCA LABORATORIES LIMITED with 91 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 49 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — IPCA LABORATORIES LIMITED, SANOFI INDIA LIMITED, GRACURE PHARMACEUTICALS LIMITED — together account for 58% of total trade value on this route. The average shipment value of $55.1K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as apohealth paracetamol pain relief 500mgtablets (paracetamol film coated tablets500mg)(93580x1x100's pack=9358000 table and apohealth paracetamol pain relief 500mgtablets (paracetamol film coated tablets500mg)(84030x10x10's pack=8403000 table, suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, NA is the largest importer with 63 shipments worth $54.4M USD — representing 46% of all paracetamol imports from India on this route. A total of 140 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $119.6M
- Avg. Shipment
- $55.1K
- Suppliers
- 49
- Buyers
- 140
- Transit (Sea)
- ~33 days
- Annual Growth
- +10.2%
Related Analysis
Reverse Direction
Australia → India — Paracetamol (Import)Other Paracetamol Routes
Unlock the Full India to Australia Paracetamol Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 2,171 shipments on this route.
Frequently Asked Questions — India to Australia Paracetamol Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Paracetamol to Australia?
The leading Indian exporters of Paracetamol to Australia are IPCA LABORATORIES LIMITED, SANOFI INDIA LIMITED, GRACURE PHARMACEUTICALS LIMITED. IPCA LABORATORIES LIMITED holds the largest market share at approximately 46% of total trade value on this route.
Q What is the total value of Paracetamol exports from India to Australia?
India exports Paracetamol to Australia worth approximately $119.6M USD across 2,171 recorded shipments. The average value per shipment is $55.1K USD.
Q Which ports does India use to ship Paracetamol to Australia?
The most active port of origin is NHAVA SHEVA SEA (INNSA1) with 647 shipments. Indian exporters primarily use sea freight for this route, with 78% of shipments going by sea and 25% by air.
Q How long does shipping take from India to Australia for Paracetamol?
The average transit time for Paracetamol shipments from India to Australia is approximately 33 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Australia Paracetamol trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 10.2% with demand growth tracking at 11.1%. The route is ranked #3 among India's top Paracetamol export destinations globally.
Q How many suppliers are active on the India to Australia Paracetamol route?
There are currently 49 active Indian suppliers exporting Paracetamol to Australia. The market is moderately concentrated with IPCA LABORATORIES LIMITED accounting for 46% of total shipment value.
Q Who are the main importers of Paracetamol from India in Australia?
The leading importers of Indian Paracetamol in Australia include NA, SANOFI-AVENTIS AUSTRALIA PTY LTD, GLAXOSMITHKLINE CONSUMER HEALTHCARE , HALEON AUSTRALIA PTY LTD, GLAXOSMITHKLINE CONSUMER HEALTHCARE. NA is the largest buyer with 63 shipments worth $54.4M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Australia export trade corridor identified from Indian Customs (DGFT) records for Paracetamol.
- 2.Supplier/Buyer Matching: 49 Indian exporters and 140 importers in Australia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 2,171 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,171 Verified Shipments
49 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists